Innovating the Future of Invasive Cardiology
Hesaplama Aracı
Bilimsel Yayınlar
Bilimsel yayın ve çalışmalarımıza bu sayfadan ulaşabilir, bizimle iletişime geçebilirsiniz.
Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study
ESC Congress 2025 Madrid
Peri-interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Non-inferiority Trial
ESC Congress 2025 Madrid
Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous coronary intervention: the TAILORED-CHIP randomized clinical trial
ESC Congress 2025 Madrid
Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial
ESC Congress 2025 Madrid
Treatment with Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT)
ESC Congress 2025 Madrid
The Pulse Randomized Controlled Trial
ESC Congress 2025 Madrid
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant masked, registry-based, randomised controlled trial
ESC Congress 2025 Madrid
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant masked, registry-based, randomised controlled trial
ESC Congress 2025 Madrid
Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION–STEMI): a multicentre, non-inferiority, open-label, randomised trial
ESC Congress 2025 Madrid
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trial
ESC Congress 2025 Madrid
Inclisiran-based treatment strategy in hypercholesterolaemia: The VICTORION-difference trial
ESC Congress 2025 Madrid
Helicobacter pylori Screening After Acute Myocardial Infarction The Cluster Randomized Crossover HELP-MI SWEDEHEART Trial
ESC Congress 2025 Madrid
EARLY WITHDRAWAL OF ASPIRIN AFTER PCI IN ACUTE CORONARY SYNDROMES
ESC Congress 2025 Madrid
Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction (TARGET-FIRST)
ESC Congress 2025 Madrid
DUAL-ACS TRIAL: DURATION OF DAPT İN ACS
ESC Congress 2025 Madrid
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
ESC Congress 2025 Madrid
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial
ESC Congress 2025 Madrid
Beta-Bloker Tedavisinin Miyokard İnfarktüsü Sonrası Kalp Yetersizliği Olmayan Hastalardaki Klinik Sonuçları: BETAMI–DANBLOCK Çalışması
ESC Congress 2025 Madrid
Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC Çalışması)
ESC Congress 2025 Madrid